These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38502866)

  • 1. Standardization of key performance indicators and metrics for investigational drug services: Consensus recommendations among IDS specialists.
    Schmidt M; Carlson LJ; Murphy J; Amin SR; Lockhorst R; Luedtke K
    Am J Health Syst Pharm; 2024 Jul; 81(14):608-614. PubMed ID: 38502866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and funding of a pharmacy-based investigational drug service.
    Ryan ML; Colvin CL; Tankanow RM
    Am J Hosp Pharm; 1987 May; 44(5):1069-74. PubMed ID: 3605116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy-coordinated investigational drug services.
    Stolar MH; Gabriel T; Grant KL; Koeller J; Letendre DE
    Am J Hosp Pharm; 1982 Mar; 39(3):232-6. PubMed ID: 7072723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance.
    Song K; Yu M; McLuckie R; O'Brien K; Harrison M; Nguyen V; Kraft M; Abdelghany O; Phillips MS; Roberts J; Johnston S; Young CA; Redic KA
    Am J Health Syst Pharm; 2023 Oct; 80(21):1557-1563. PubMed ID: 37335865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of pharmacy-coordinated investigational drug services.
    Cipywnyk DM; McBride J
    Can J Hosp Pharm; 1991 Aug; 44(4):183-8, 200. PubMed ID: 10112895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy-based investigational drug services: a national survey.
    Rockwell K
    Top Hosp Pharm Manage; 1993 Apr; 13(1):1-15. PubMed ID: 10128788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of pharmacy-coordinated investigational drug services.
    Young LM; Haakenson CM; Weber JH; Tosch TJ
    Am J Hosp Pharm; 1984 Sep; 41(9):1792-6. PubMed ID: 6496514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marketing an investigational drug service.
    Johnson VB; Crane V; Hayman JN
    Top Hosp Pharm Manage; 1993 Apr; 13(1):16-28. PubMed ID: 10128789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving investigational drug service operations through development of an innovative computer system.
    Sweet BV; Tamer HR; Siden R; McCreadie SR; McGregory ME; Benner T; Tankanow RM
    Am J Health Syst Pharm; 2008 May; 65(10):969-73. PubMed ID: 18463347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group.
    Finnes HD; Child B; DeFrates S; Kinsman K; Thorne A; Lentz S; Lockhorst R; Murphy J; Urmanski A; Amin S; Barr H; Baviskar S; Beckman C; Chow N; Derba M; Erickson M; Hennes E; Heisey H; Lau R; Limvorasak S; Luckritz T; Mays T; Nzelibe CN; Romanowski T; Smith C; Tesoro D; Toeniskoetter K; Voytilla K
    Am J Health Syst Pharm; 2023 Jan; 80(1):e67-e73. PubMed ID: 36200957
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of medication safety resources in pediatric hospitals.
    Nelson KL; Morvay S; Neidecker M; Sebastian S; Fischer J; Li J; Pai V; Merandi J
    Am J Health Syst Pharm; 2020 Aug; 77(Suppl 3):S78-S86. PubMed ID: 32815535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Economic Value of Pharmacy Resident Participation in an Investigational Drug Service.
    Brown JN; Gordon SE; Tillman F; Jacob S; Britnell SR
    J Pharm Pract; 2021 Feb; 34(1):23-27. PubMed ID: 31232150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Evaluating Practice-Related Activities of Pharmacy Faculty.
    Haines ST; Haines SL; MacLaughlin EJ; Van Amburgh JA
    Ann Pharmacother; 2017 Apr; 51(4):345-353. PubMed ID: 27927795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of health-system inpatient pharmacy clinical metrics.
    Cassat S; Massey L; Buckingham S; Kemplay T; Little J
    Am J Health Syst Pharm; 2019 Nov; 76(23):1958-1964. PubMed ID: 31687757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit.
    Baroody C; Sandler M; Hong C; Madanat YF; Conley S
    J Oncol Pharm Pract; 2023 Oct; ():10781552231207854. PubMed ID: 37847779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Training workload in the investigational drug service of a university hospital center.
    Martel-Côté N; Choquette R; Côté-Sergerie C; Lebel D; Bussières JF; Tanguay C
    Am J Health Syst Pharm; 2023 Apr; 80(8):495-502. PubMed ID: 36626282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical research: national survey of U.S. pharmacy-based investigational drug services--1997.
    Rockwell K; Bockheim-McGee C; Jones E; Kwon IW
    Am J Health Syst Pharm; 1999 Feb; 56(4):337-44. PubMed ID: 10690217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a personal computer to support an investigational drug service.
    Abel JF; Moore RA; Foster TJ
    Hosp Pharm; 1990 Feb; 25(2):127-33. PubMed ID: 10103700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing oncology research protocols.
    Lunik MC
    Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.